Dr. Angelo Nascimbene, MD

Dr. Nascimbene practices at Memorial Hermann-Texas Medical Center in Houston, Texas, part of Memorial Hermann Health System.

Dr. Nascimbene's NPI, 1174872253, was assigned on September 5, 2012. Dr. Nascimbene graduated from University of Milan Faculty of Medicine in 2001. Dr. Nascimbene holds Texas license P3357.

Dr. Nascimbene's primary practice is Memorial Hermann-Texas Medical Center, at 6411 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 704-3700.

Dr. Nascimbene's primary practice is Memorial Hermann-Texas Medical Center in Houston, Texas, part of Memorial Hermann Health System. Dr. Nascimbene is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is UT Physicians. Dmand AI also links Dr. Nascimbene to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nascimbene practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Nascimbene's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Nascimbene is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Nascimbene's licenses on file in 2 states: Texas and California.

Dmand AI lists angioplasty, atherosclerosis, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, circulation problems and coronary artery disease among the conditions Dr. Nascimbene treats.

CMS data shows 660 Medicare services from Dr. Nascimbene across 8 procedure codes in 2024, for 270 Medicare patients. Medicare paid $38,798 for them.

CMS counts 270 Medicare patients who saw Dr. Nascimbene in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have heart failure, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nascimbene's median patient age at 71, with 41% women.

In 2024, Dr. Nascimbene wrote 1,243 Medicare Part D claims for 134 patients. 70% of them were for generic drugs. CMS names the drug for 1,047 of them, across 25 drugs with 11 or more claims each, at $290,884 in total drug cost. In 2023, CMS named 1,106 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Nascimbene for performance year 2024, reported as part of a group. Dr. Nascimbene accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 43 papers to Dr. Nascimbene, published from 2004 to 2024. 2016 was the busiest year, with 5. The most frequent topics are Heart-Assist Devices, Prosthesis Design and Aortic Valve Stenosis. Dr. Nascimbene has published most often in Tex Heart Inst J. Dr. Nascimbene's most frequent co-authors are Igor Darko Gregoric, MD, Biswajit Kar, MD and Pranav Loyalka, MD.

Dmand AI links Dr. Nascimbene to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Tricuspid Valve Insufficiency, Ventricular Outflow Obstruction and Aortic Valve Stenosis.

CMS Open Payments shows 142 general payments to Dr. Nascimbene from 24 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 49% of the total. Abbott Laboratories paid the most, $5,967. It also lists 1 research payment totaling $113 in 2023.

Dr. Nascimbene graduated from University of Milan Faculty of Medicine in 2001. Dr. Nascimbene is a member of ACC.

Dr. Nascimbene is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.